1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. KYMERA THERAPEUTICS INC
Kymera Therapeutics Inc XNAS: KYMR

Kymera Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' li...

Read More
74.77 -0.21 (-0.28%)
27.41% Fall from 52W High
594.8K
XNAS Volume

XNAS 09 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Kymera Therapeutics Inc is on 13 Jan 2026 for the purpose of 44(th) Annual J.P. Morgan Healthcare Conference See details
Durability score
Low Financial Strength
11.1 / 100
Valuation Score
Expensive Valuation
6.3 / 100
Momentum Score
Technically Moderately Bullish
65.7 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
117
1Yr Price target upside is 56%
21 analysts

7

S

13

W

1

O

2

T

SWOT Analysis

Kymera Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..